16:51 EST Inhibikase Therapeutics (IKT) files to sell 58.31M shares of common stock for holders
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IKT:
- Inhibikase Therapeutics Reports Q3 2024 Financial Results
- Inhibikase Therapeutics reports Q3 EPS (65c), consensus (48c)
- Inhibikase Therapeutics, Inc. (IKT) Q3 Earnings Cheat Sheet
- Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
- Inhibikase Therapeutics initiated with a Buy at Jefferies